Stockscreener 앱 받기
35.71
0.75%
-0.27
전일 마감가:
$35.98
열려 있는:
$36.2
하루 거래량:
2.54M
Relative Volume:
1.68
시가총액:
$8.15B
수익:
$5.30B
순이익/손실:
$-624.00M
주가수익비율:
-11.63
EPS:
-3.0692
순현금흐름:
$42.00M
1주 성능:
-2.16%
1개월 성능:
+0.53%
6개월 성능:
-18.00%
1년 성능:
-40.43%
1일 변동 폭
$35.13
$36.82
1주일 범위
$35.13
$36.94
52주 변동 폭
$32.45
$62.30
Lineage Inc Stock (LINE) Company Profile
명칭
Lineage Inc
전화
(800) 678-7271
주소
46500 HUMBOLDT DRIVE, NOVI
LINE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LINE
Lineage Inc
|
35.71 | 8.21B | 5.30B | -624.00M | 42.00M | -3.0692 |
|
PLD
Prologis Inc
|
130.56 | 121.13B | 8.79B | 3.57B | 4.27B | 3.5567 |
|
PSA
Public Storage
|
276.19 | 48.68B | 4.79B | 1.91B | 2.93B | 9.6238 |
|
EXR
Extra Space Storage Inc
|
137.97 | 29.47B | 3.34B | 997.83M | 1.73B | 4.4718 |
|
EGP
Eastgroup Properties Inc
|
181.64 | 9.67B | 679.77M | 236.60M | 385.49M | 4.6371 |
|
REXR
Rexford Industrial Realty Inc
|
40.53 | 9.35B | 903.94M | 275.97M | 94.31M | 1.23 |
Lineage Inc Stock (LINE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-13 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-12-18 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-07-01 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-06-23 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-06-23 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-06-12 | 다운그레이드 | BNP Paribas Exane | Neutral → Underperform |
| 2025-05-06 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-04-10 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-28 | 개시 | Citigroup | Neutral |
| 2025-01-14 | 개시 | Exane BNP Paribas | Neutral |
| 2024-12-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-09-18 | 개시 | CapitalOne | Overweight |
| 2024-09-16 | 개시 | CapitalOne | Overweight |
| 2024-08-19 | 개시 | Deutsche Bank | Hold |
| 2024-08-19 | 개시 | Evercore ISI | In-line |
| 2024-08-19 | 개시 | Goldman | Buy |
| 2024-08-19 | 개시 | JP Morgan | Overweight |
| 2024-08-19 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-08-19 | 개시 | Mizuho | Neutral |
| 2024-08-19 | 개시 | Morgan Stanley | Overweight |
| 2024-08-19 | 개시 | Piper Sandler | Overweight |
| 2024-08-19 | 개시 | Robert W. Baird | Outperform |
| 2024-08-19 | 개시 | Scotiabank | Sector Outperform |
| 2024-08-19 | 개시 | Truist | Buy |
| 2024-08-19 | 개시 | UBS | Neutral |
| 2024-08-19 | 개시 | Wells Fargo | Equal Weight |
모두보기
Lineage Inc 주식(LINE)의 최신 뉴스
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Stockholders to Connect - Stockhouse
Lineage Focused on Bringing Certainty to Global Movement of Food - Nareit
Strs Ohio Lowers Holdings in Lineage, Inc. $LINE - MarketBeat
Is Lineage Inc. benefiting from innovation trends2025 Earnings Impact & Free Community Consensus Stock Picks - mfd.ru
Lineage, Inc. Announces Tax Treatment for 2025 Distributions - Yahoo Finance
Hedge Fund Moves: Can Lineage Cell Therapeutics Inc maintain sales growth2025 Volatility Report & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Lineage subsidiary proposes euro-denominated notes offering - MSN
U.S. Cold Storage Market to Reach US$ 91.4 Bn by 2032 as Key Players - openPR.com
Trade Report: Is Lineage Cell Therapeutics Inc a top pick in the sectorRisk Management & Verified Entry Point Detection - baoquankhu1.vn
Lineage, Inc. (NASDAQ:LINE) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Market Wrap: Can Lineage Inc deliver alphaDollar Strength & Expert Curated Trade Ideas - baoquankhu1.vn
Market Moves: Is Lineage Cell Therapeutics Inc trading at a discountShare Buyback & Long-Term Safe Investment Plans - baoquankhu1.vn
What are the future prospects of Lineage Cell Therapeutics IncJuly 2025 Snapshot & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Guidance Update: Will Lineage Cell Therapeutics Inc stock hit new highs in YEARMarket Trend Review & Momentum Based Trading Signals - baoquankhu1.vn
Trade Recap: Will Lineage Cell Therapeutics Inc benefit from rising consumer demandTrade Exit Summary & Advanced Technical Signal Analysis - baoquankhu1.vn
Analysts Offer Insights on Real Estate Companies: Digital Realty (DLR) and Lineage, Inc. (LINE) - The Globe and Mail
What is Lineage Inc. s P E ratio telling usM&A Rumor & Safe Capital Growth Plans - mfd.ru
Lineage Therap Sells 12 Million Shares to Janus - MSN
Trading Recap: What are the analyst revisions for AFJKUIs Lineage Inc stock a good investment in YEARQuarterly Trade Review & Daily Oversold Bounce Ideas - baoquankhu1.vn
Aug Action: Can Lineage Inc be the next market leaderQuarterly Portfolio Summary & Daily Oversold Bounce Ideas - baoquankhu1.vn
Aug Levels: Is GFL Environmental Inc stock showing strong momentum2025 Trading Recap & AI Based Trade Execution Alerts - baoquankhu1.vn
Travel Stocks: Can Lineage Inc outperform under higher oil pricesJuly 2025 Review & Community Driven Trade Alerts - baoquankhu1.vn
Assessing Lineage (LINE) Valuation As Analyst Downgrades Reset Market Expectations - simplywall.st
Lineage to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 25, 2026 - Business Wire
Market Overview: Should I average down on Lineage Cell Therapeutics Inc stockEarnings Trend Report & Accurate Technical Buy Alerts - baoquankhu1.vn
Lineage (NASDAQ:LINE) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat
The Bull Case For Lineage (LINE) Could Change Following Barclays Downgrade And Rising Analyst Caution - Sahm
Lineage Takes Delivery of Genetically Engineered iPSC Line with Hypoimmunity Edits from Factor Bioscience - BioInformant
Aug PostEarnings: Can Lineage Cell Therapeutics Inc stock outperform in 2025 bull market - moha.gov.vn
Lineage Shares Fall After Barclays Downgrade - marketscreener.com
Aug Sentiment: Will Lineage Inc stock deliver strong dividend growth2025 Valuation Update & Long Hold Capital Preservation Plans - moha.gov.vn
LINE: Barclays Downgrades Lineage, Lowers Price Target to $38.00 - GuruFocus
Lineage (NASDAQ:LINE) Given "Equal Weight" Rating at Barclays - MarketBeat
Barclays Downgrades Lineage to Equalweight From Overweight, Lowers Price Target to $38 From $47 - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Shareholders to Connect - ACCESS Newswire
Lineage, Inc. Reports Mixed Sentiment in Earnings Call - MSN
Aug Update: Why hedge funds are buying Lineage Inc stockTrade Entry Summary & Community Verified Swing Trade Signals - moha.gov.vn
Lineage, Inc. Prices €700M Senior Notes Offering - MSN
CEO Moves: Why Lineage Cell Therapeutics Inc stock remains a top recommendationMarket Movers & Verified Momentum Stock Alerts - moha.gov.vn
What dividend safety score for Lineage Cell Therapeutics Inc. stock2025 Geopolitical Influence & Safe Entry Point Alerts - ulpravda.ru
Why hedge funds are buying Lineage Inc. stockJuly 2025 Outlook & Advanced Swing Trade Entry Alerts - ulpravda.ru
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lineage, Inc. (LINE) And Encourages Shareholders to Reach Out - ACCESS Newswire
Will Lineage Inc. stock benefit from automationMarket Performance Recap & Risk Managed Investment Signals - ulpravda.ru
What dividend safety rating applies to Lineage Cell Therapeutics Inc. stock2025 Technical Overview & Target Return Focused Picks - ulpravda.ru
Why Lineage Cell Therapeutics Inc. stock is a must watch in 2025Earnings Beat & AI Powered Market Entry Strategies - ulpravda.ru
Earnings Miss: Can Lineage Cell Therapeutics Inc. stock resist sector downturnsJuly 2025 Gainers & Reliable Entry Point Trade Alerts - ulpravda.ru
CEO Change: What dividend safety rating applies to Lineage Cell Therapeutics Inc. stock2025 AllTime Highs & Daily Stock Trend Reports - ulpravda.ru
Can Lineage Inc. stock surprise with earnings upsideLow Beta Stocks & Free Superior Stock Performance - ulpravda.ru
US Cold Storage Market 2026-2033: Growth Overview, Facts & - openPR.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lineage, Inc. (LINE) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience - PharmiWeb.com
Lineage Inc (LINE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.21%
0.62%
자본화:
|
볼륨(24시간):